• Citer

Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.

par Souery, Daniel ;Serretti, Alessandro;Calati, Raffaella;Oswald, Pierre ;Massat, Isabelle ;Konstantinidis, Anastasios;Linotte, Sylvie ;Kasper, Siegfried;Montgomery, Stuart;Zohar, Joseph;Mendlewicz, Julien
Référence The world journal of biological psychiatry, 12, 5, page (364-375)
Publication Publié, 2011-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.
Auteur:	Souery, Daniel; Serretti, Alessandro; Calati, Raffaella; Oswald, Pierre; Massat, Isabelle; Konstantinidis, Anastasios; Linotte, Sylvie; Kasper, Siegfried; Montgomery, Stuart; Zohar, Joseph; Mendlewicz, Julien
Informations sur la publication:	The world journal of biological psychiatry, 12, 5, page (364-375)
Statut de publication:	Publié, 2011-08
Sujet CREF:	Sciences bio-médicales et agricoles
	Sciences humaines
Mots-clés:	Antidepressants
	Major depressive disorder
	Pharmacotherapy
	Resistant depression
	Switch
MeSH keywords:	Antidepressive Agents, Second-Generation -- therapeutic use
	Antidepressive Agents, Tricyclic -- therapeutic use
	Citalopram -- therapeutic use
	Depressive Disorder, Major -- drug therapy
	Desipramine -- therapeutic use
	Female
	Humans
	Male
	Middle Aged
	Psychiatric Status Rating Scales
	Serotonin Uptake Inhibitors -- therapeutic use
	Treatment Outcome
Note générale:	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1562-2975
	info:doi/10.3109/15622975.2011.590225
	info:scp/79960779425
	info:pmid/21718212